• Cyclosporin A, EvoPure packaged and labeled.

click on thumbnail to zoom
SKU: C042

  Click 'Bulk Order' for 10 or more
Price: make selection(s)

Cyclosporin A (CsA) is a neutral, cyclic oligopeptide immunosuppressant compound routinely given to patients after receiving an organ transplant to prevent transplant rejection. Cyclosporin A (CsA) shows the most potent immunosuppressant activity of the cyclosporins and is highly metabolized by humans and animals after ingestion. The resulting metabolites (cyclosporin B, C, D, E, H, L, and others) have been found to have less potent immunosuppressant activity and are associated with higher nephrotoxicity when compared to cyclosporin A (CsA). Cyclosporin A (CsA) has been successful for liver, kidney, bone marrow, and pancreas transplant recipients as well as pateints with autoimmune disorders.

For more cyclosporin products, click here.

    CAS Number


    Molecular Formula


    Molecular Weight

    1202.6 g/mol

    Mechanism of Action

    Cyclosporin A (CsA) immunosuppressant activity stems from its ability to prevent T-cell activation by blocking specific cytokine transcription genes. After entering a T-cell, cyclosporin A (CsA) associates with ubiquitous cytosolic proteins called cyclophilins which aid in protein folding. Cyclosporin A (CsA) : cyclophilin complexes together bind calcineurin, (another cytosolic protein) effectively blocking the pathway to IL-2 gene transcription and nitric oxide synthesis by TNFα and interleukin 1α.

    Storage Conditions


    Tariff Code



    Cancer Applications

    Cyclosporins can be used to study toxicity and immunosuppressant activity in various in vitro assays and experiments.





    White powder


    Tolypocladium inflatum


    ≥99.0% (HPLC, as is)

Technical Data

Spectral Data - Cyclosporin A, EvoPure®

HNMR Spectra


Click to enlarge

Solvent: cdc13
Instrument: Mercury 300
Frequency: 300 MHz


FTIR Spectra

Click to enlarge

Mass Spectra

Click to enlarge

Polarity/Scan Type: Positive
Solvent: MeOH
Solution Concentration: 10 mg/mL
Instrument: Agilent


    Stiller, C. R., MD, and R. A. Ulan, MD. "Cyclosporin A: A Powerful Immunosuppressant."Canadian Medical Association 126 (1981): 1041-046. www.ncbi.gov. Web. 27 Aug. 2012.

    Crabtree, G. R., J. Nourse, and L. Timmermann. "The Mechanism of Action of Cyclosporin A and FK506." Clinical Immunology and Immunotherapy (1996): 40-45.www.ncbi.gov. Web. 27 Aug. 2012.

    Wang, Paul C. et. al. "Isolation of 10 Cyclosporine Metabolites from Human Bile." Drug Metabolism and Disposition 17.3 (1989): 292-96. Nih.gov. Web. 28 Oct. 2013.

    Copeland, Kenneth R. "Immunosuppressive Activity of Cyclosporine Metabolites Compared and Characterized by Mass Spectrometry and Nuclear Magnetic Resonance."Clinical Chemistry 36.2 (1990): 225-29. Web. 28 Oct. 2013.

    Matsuda, Staoshi. "Mechanisms of Action of Cyclosporine." Immunopharmacology 47 (2000): 119-25. Elsevier. Web. 28 Oct. 2013.

    Laupacis, A., and P. A. Keown. "Cyclosporin A: A Powerful Immunosuppressant." Therapeutic Review 126 (1982): 1041-046. Nih.gov. Web. 6 Nov. 2013.

Other Items In This Category